FindTrial
Sign In

Functional mechanism of liver cancer infiltrating natural immune cells

Functional mechanism of liver cancer infiltrating natural immune cells

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020787
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-02-16
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with primary hepatocellular carcinoma were treated with surgery

Exclusion criteria

Exclusion criteria: Hepatitis c virus infection, drug, autoimmune, schistosomiasis, metabolic and other causes of liver cirrhosis; Other tumors and liver metastases; Hepatic space-occupying lesions were undiagnosed as HCC cases.

Design outcomes

Primary

MeasureTime frame
serum HBsAg quantitation;HBV DNA quantitation;phenotype and function change of immunocyte;—

Countries

China

Contacts

Public ContactSun Cheng

University of Science and Technology of China

charless@ustc.edu.cn+86 13956074139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026